Research Topics
Genomes and Genes | M O SavageSummaryAffiliation: Queen Mary Country: UK Publications
| Collaborators
|
Detail Information
Publications
Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatmentRaja Padidela
Department of Endocrinology, Barts and London School of Medicine and Dentistry, London, UK
Horm Res 70:129-36. 2008..GH therapy, using doses similar to those approved for Turner syndrome (TS), induced short-term increases in height velocity over 1-3 years, and may improve final adult height with longer-term treatment...
Phenotypic aspects of growth hormone- and IGF-I-resistant syndromesMartin O Savagea
Department of Endocrinology, William Harvey Research Institute, London, UK
Endocr Dev 14:143-50. 2009..We discuss the current status of endocrine and molecular evaluation, focussing on the phenotypic characteristics of genetic defects in the GH-IGF-I axis...
Growth in disorders of adrenal hyperfunctionM O Savage
Department of Endocrinology, St Bartholomew s and the Royal London School of Medicine and Dentistry, London, UK
Horm Res 58:39-43. 2002..After cure by TSS or pituitary irradiation, GH deficiency was frequent and persisted for many years. Treatment with hGH induced significant long-term catch-up growth leading to reasonable final height...
Work-up and management of paediatric Cushing's syndromeMartin O Savage
Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, UK
Curr Opin Endocrinol Diabetes Obes 15:346-51. 2008..A protocol for investigation of the child with suspected Cushing's syndrome is presented followed by principles of management...
Management of chronic systemic diseasesMartin O Savage
William Harvey Research InstituteJohn Vane Science CentreLondon, UK
Horm Res 68:112. 2007
Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?Martin O Savage
Endocrinology Centre, William Harvey Research Institute, Queen Mary, University of London, London, EC1M 6BQ UK
Eur J Endocrinol 157:S33-7. 2007..Genetic analysis for single-gene defects has made enormous contributions to understanding the physiology of growth regulation. Can this type of investigation help in predicting growth responses to GH or IGF-I therapy?..
Abnormal growth in noonan syndrome: the challenge of optimal therapyMartin O Savage
Department of Endocrinology, Barts and the London School of Medicine and Dentistry, London, UK
Pediatr Endocrinol Rev 6:523-8. 2009..GH therapy induces short-term increases in height velocity over 1-3 years, and is likely to improve adult height...
Diagnosis and treatment of pediatric Cushing's diseaseMartin O Savage
Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK
Pituitary 10:365-71. 2007..The management of pediatric CD patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
Diagnosis and treatment of Cushing's disease in childrenMartin O Savage
Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Barts and the Royal London NHS Trust, London, UK
Endocr Dev 17:134-45. 2010..The management of paediatric CD patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
Phenotypic variability in growth hormone insensitivityMartin O Savage
Department of Endocrinology, St. Bartholomew 's and The Royal London School of Medicine and Dentistry, London, UK
J Pediatr Endocrinol Metab 15:1449-50. 2002
The continuum of growth hormone-IGF-I axis defects causing short stature: diagnostic and therapeutic challengesMartin O Savage
Department of Endocrinology, William Harvey Research Institute, Barts and the Royal London School of Medicine and Dentistry, London, UK
Clin Endocrinol (Oxf) 72:721-8. 2010..We consider appropriate therapy for patients with abnormal auxology and subnormal adult height prognosis, highlighting new data to clarify therapeutic choices leading to optimal clinical outcome...
Therapeutic applications of the insulin-like growth factorsMartin O Savage
Research Centre in Clinical and Molecular Endocrinology, William Harvey Research Institute, Queen Mary s School of Medicine and Dentistry, Queen Mary s, University of London, London, UK
Growth Horm IGF Res 14:301-8. 2004..Improved glycaemic control has been reported in type 1 and type 2 diabetes in adults. A therapeutic trial in naïve children with GHIS is currently under way...
Transitional care of GH deficiency: when to stop GH therapyM O Savage
Department of Endocrinology, Barts and the Royal London School of Medicine and Dentistry, London, UK
Eur J Endocrinol 151:S61-5. 2004..Quality of life does not appear to be decreased in adolescents with GHD who stop treatment, so achievement of satisfactory bone mass is a major determinant of the decision whether to continue therapy...
IGFs and IGFBPs in GH insensitivityM O Savage
Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, UK
Endocr Dev 9:100-6. 2005..In our experience, IGF-I is more sensitive to disturbance of GH action that IGFBP-3, however in severe GHIS cases, IGF-I is usually undetectable and measurement of IGFBP-3 is valuable as a guide to the severity of the biological defect...
Advances in the management of paediatric Cushing's diseaseMartin O Savage
Department of Endocrinology, Barts and the London School of Medicine and Dentistry, London, UK
Horm Res 69:327-33. 2008..The management of paediatric CD patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
Growth hormone treatment in children on chronic glucorticoid therapyMartin O Savage
Department of Endocrinology, William Harvey Research Institute, Barts and the Royal London School of Medicine and Dentistry, Charterhouse Square, London, UK
Endocr Dev 20:194-201. 2011..Collaboration between paediatric endocrinologists and other subspecialists will improve the opportunity for successful GH therapy. Treatment should be initiated before or during early puberty...
Pathophysiology, assessment and management of the child with growth hormone resistanceM O Savage
Department of Endocrinology, William Harvey Research Institute, Barts and Royal London School of Medicine and Dentistry, London, UK
Pediatr Endocrinol Rev 7:347-56. 2010..Finally we discuss therapy with IGF-I within the limits of the USA Food and Drug Administration and European Medicines Agency labels for GH resistance...
Global inequalities in paediatric endocrine practice: statement of minimal acceptable care. Statement from the international societies for paediatric endocrinologyMartin O Savage
Paediatric Endocrinology Section, Department of Endocrinology Barts and the London School of Medicine and Dentistry, John Vane Science Centre Charterhouse Square, London
Horm Res 65:111-3. 2006
Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disordersMartin O Savage
Paediatric Endocrinology Unit, William Harvey Research Institute, St Bartholomew s Hospital and the London School of Medicine and Dentistry, London, UK
Nat Clin Pract Endocrinol Metab 2:395-407. 2006....
Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growthP V Carroll
Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, United Kingdom
J Clin Endocrinol Metab 89:3890-5. 2004....
Acid-labile subunit deficiency and growth failure: description of two novel casesA David
Centre for Endocrinology, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, UK
Horm Res Paediatr 73:328-34. 2010..Conclusion: Screening of the IGFALS is important in children with short stature associated with low serum IGF-I, IGFBP-3 and ALS...
Diagnosis, management and therapeutic outcome in prepubertal Cushing's diseaseR P Dias
Department of Endocrinology, Barts and the Royal London School of Medicine and Dentistry, London EC1A 7BE, UK
Eur J Endocrinol 162:603-9. 2010..Cushing's disease (CD) in prepubertal children is very rare and presents important diagnostic and therapeutic challenges. We report experience of the management of this subpopulation of CD patients...
Cushing's disease in childhood: presentation, investigation, treatment and long-term outcomeM O Savage
Department of Endocrinology, St Bartholomew s and the Royal London School of Medicine and Dentistry, London, UK
Horm Res 55:24-30. 2001..93 +/- 1.13, i.e. less (p = 0.005) than the difference between height SDS and target height SDS at presentation, i.e. 1.72 +/- 1.26, indicating long-term catch-up growth...
Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrationsC C Dupuis
Department of Endocrinology, Barts and the Royal London School of Medicine and Dentistry, London, UK
Clin Endocrinol (Oxf) 66:838-43. 2007..Paediatric Cushing's disease is frequently associated with abnormal puberty. We addressed the hypothesis that prepubertal patients show excessive virilization and pubertal patients show suppression of LH and FSH secretion...
Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndromeA Weber
Division of Paediatric Endocrinology, St Bartholomew s Hospital, London, UK
Clin Endocrinol (Oxf) 43:19-28. 1995..Cushing's syndrome in childhood and adolescence is rare. We analysed the clinical presentation, investigation, management and therapeutic outcome in 12 paediatric patients with Cushing's syndrome...
Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivityA David
William Harvey Research Institute, Centre for Endocrinology, Queen Mary University of London, Barts and The London, London, UK
Eur J Endocrinol 162:37-42. 2010..Design: We investigated the effect of the novel defect on mRNA splicing using an in vitro splicing assay and a cell transfection system...
Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapyL F Chan
Departments of Endocrinology, St Bartholomew s and the Royal London School of Medicine and Dentistry, London, UK
Eur J Endocrinol 156:477-82. 2007..Although the short-term effects of pituitary RT are well documented, there are less data on possible long-term sequelae. We report the long-term anterior pituitary function in a cohort of paediatric CD patients treated with pituitary RT...
Final adult height and body mass index after cure of paediatric Cushing's diseaseJ H Davies
Department of Endocrinology, Barts and the Royal London School of Medicine and Dentistry, London EC1A 7BE, UK
Clin Endocrinol (Oxf) 62:466-72. 2005..Linear growth data after cure of paediatric Cushing's disease (CD) have been reported infrequently. We evaluated final adult height (FH) and body mass index (BMI) in a cohort of paediatric patients treated successfully for CD...
The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growthW M Drake
Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, United Kingdom
J Clin Endocrinol Metab 88:1658-63. 2003..This may predispose to clinically significant osteopenia in later adult life...
Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's diseaseS Scommegna
Department of Endocrinology, St Bartholomew's Hospital, Birmingham, UK
J Endocrinol Invest 28:231-5. 2005..03 (-0.53-0.38). These findings show variability of BMD at diagnosis and near normal BMD after cure of pediatric CD, suggesting that with appropriate replacement of pituitary hormone deficiency normal peak bone mass is achievable...
An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypesA David
Centre for Endocrinology, William Harvey Research Institute, University of London, London EC1M 6BQ, United Kingdom
J Clin Endocrinol Metab 92:655-9. 2007..We previously described four mildly affected GHI patients with an intronic mutation in the GHR gene (A(-1)-->G(-1) substitution in intron 6), resulting in the activation of a pseudoexon (6Psi) and inclusion of 36 amino acids...
Growth abnormalities associated with adrenal disorders and their managementM O Savage
Department of Endocrinology, St Bartholomew s and Royal London School of Medicine and Dentistry, London EC1A 7BE, UK
Horm Res 56:19-23. 2001..Disturbance of linear growth is an important feature of many patients with adrenal disorders in childhood. Assessment of its pathogenesis and careful management are necessary to ensure optimal final adult height...
Growth hormone insensitivity: pathophysiology, diagnosis, clinical variation and future perspectivesM O Savage
Department of Endocrinology, St Bartholomew s Hospital, and the Royal London School of Medicine and Dentistry, UK
Horm Res 55:32-5. 2001..GH sensitivity, measured by IGF-I and IGFBP-3 responses in the IGF-I generation test, may reveal abnormalities in ISS, although it is likely that the dose of recombinant human GH and frequency of sampling in the test need to be modified...
Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's diseaseL F Chan
Paediatric Endocrinology, Barts and the London School of Medicine and Dentistry, London, UK
Horm Res Paediatr 75:441-6. 2011..Psychosis secondary to paediatric Cushing's disease (CD) is extremely rare and presents a significant management challenge...
Linear growth and body mass index in pediatric patients with Cushing's disease or simple obesityJ E Greening
Department of Endocrinology, Barts and the London School of Medicine and Dentistry, London, UK
J Endocrinol Invest 29:885-7. 2006..17 (p<0.0001). CONCLUSIONS: Simple, accurate measurement of height and BMI SDS values provides a quick, and sensitive diagnostic discriminator in pediatric patients with CD or SO, thus potentially avoiding complex investigations...
Normal final height and apparent cure after pituitary irradiation for Cushing's disease in childhood: long-term follow-up of anterior pituitary functionL B Johnston
Department of Endocrinology, St Bartholomew s Hospital, London, UK
Clin Endocrinol (Oxf) 48:663-7. 1998..Collaboration between the paediatric and adult departments and an experienced radiotherapist contributed to the successful outcome of these two patients...
Factors influencing skeletal maturation at diagnosis of paediatric Cushing's diseaseC J Peters
Department of Paediatric, The Royal London Hospital, London, UK
Horm Res 68:231-5. 2007..We assessed factors contributing to skeletal maturation in patients with paediatric CD...
Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's diseaseH L Storr
Department of Paediatric Endocrinology, Barts and the London School of Medicine and Dentistry, London EC1A 7BE, UK
Eur J Endocrinol 164:667-74. 2011..There are few published comparisons between paediatric and adult-onset Cushing's disease (CD). We compare the epidemiology, diagnostic features and cure rate by transsphenoidal surgery (TSS) in these groups...
Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocityJ M Kirk
Department of Endocrinology, St Bartholomew s Hospital, London, UK
Clin Endocrinol (Oxf) 41:487-93. 1994..We, therefore, studied the clinical response of children with idiopathic short stature to treatment with GHRH(1-29)NH2 (GHRHa) for a period of 12 months...
Is there a medical need to explore the clinical use of insulin-like growth factor I?M O Savage
St Bartholomew s and the Royal London School of Medicine and Dentistry, UK
Growth Horm IGF Res 11:S65-9. 2001..It will probably be decided during the next decade whether use of IGF-I or the IGF-I-IGFBP-3 complex becomes firmly established as an accepted endocrine therapy...
Cosegregation of a novel homozygous CYP11B1 mutation with the phenotype of non-classical congenital adrenal hyperplasia in a consanguineous familyC J Peters
Department of Endocrinology, Royal London Hospital, London, UK
Horm Res 67:189-93. 2007..These findings suggest that this homozygous mutation affects 11beta-hydroxylase function, resulting in the clinical features of non-classical adrenal hyperplasia in this family...
Response to growth hormone-releasing hormone as evidence of hypothalamic defect in optic nerve hypoplasiaA A Leaf
Department of Child Health, St Bartholomew s Hospital, London, UK
Acta Paediatr Scand 78:436-9. 1989..One child has shown an excellent response to treatment with subcutaneous GHRH, which is physiologically the most appropriate treatment for this condition...
Growth hormone deficiency following radiotherapy for orbital and parameningeal sarcomasA G Goddard
Department of Paediatric Oncology, St Bartholomew s Hospital, London, UK
Pediatr Hematol Oncol 16:23-33. 1999..7 years. Treatment with hGH resulted in a median increase in height SDS of 0.9. Careful surveillance with timely introduction of GH replacement is required for treatment of GHD following treatment of orbital and parameningeal sarcomas...
Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretionP V Carroll
Department of Endocrinology, St Bartholomew s and the Royal London School of Medicine and Dentistry, London, UK
Clin Endocrinol (Oxf) 60:169-74. 2004..Whether recovery of spontaneous GH secretion occurs following treatment of childhood CD has yet to be established...
Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndromeC P Burren
Paediatric Section, Dept. of Endocrinology, St. Bartholomew's Hospital, London EC1A 7BE, UK
Horm Res 55:125-30. 2001..GH insensitivity may be present in children with short stature and an otherwise normal appearance...
Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing's syndromeA Lienhardt
Department of Endocrinology, St. Bartholomew's and Royal London School of Medicine and Dentistry, London, United Kingdom EC1 7BE
J Clin Endocrinol Metab 86:5711-4. 2001..In experienced hands, however, IPSS was feasible in this age group, safe, and strongly predictive of the site of the adenoma, leading to a high rate of successful surgical outcome...
Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasiaH L Storr
Department of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK
Clin Endocrinol (Oxf) 61:553-9. 2004..Adrenals were normal or small on imaging. PRKAR1A gene analysis may be helpful in the assessment of these patients...
Clinical and endocrine features and long-term outcome of Graves' disease in early childhoodA T Bossowski
Department of Paediatric Endocrinology Barts and London School of Medicine and Dentistry, London, UK
J Endocrinol Invest 30:388-92. 2007..2) or radioiodine (no.=2). In conclusion, disturbance of growth, behavioral difficulties and infrequent spontaneous remission are key features of Graves' disease in early childhood...
Pediatric endocrine screening for von Hippel-Lindau disease: benefits and the challenge of complianceR Prasad
Paediatric Endocrine Unit, St Bartholomew s and Royal London Hospitals, London, UK
J Endocrinol Invest 34:296-9. 2011..A formal screening programme for this at-risk population of pediatric patients, despite being intensive, can identify VHL lesions during a pre-morbid phase and may thus have a beneficial impact on prognosis in this serious disorder...
Excellent growth response to growth hormone therapy in a child with PTPN11-negative Noonan syndrome and features of growth hormone resistanceS Walton Betancourth
Department of Endocrinology, St Bartholomew s and The Royal London Hospitals, London, UK
J Endocrinol Invest 30:439-41. 2007..This case shows that the potential value of GH therapy must be evaluated in each patient individually and that an excellent response may occur in a child with a PTPN11-negative genotype...
Benefits of screening in von Hippel-Lindau disease--comparison of morbidity associated with initial tumours in affected parents and childrenM Priesemann
Department of Endocrinology, Barts and The London NHS Trust, London, UK
Horm Res 66:1-5. 2006..These observations strongly support the recommendation to undertake screening of the children of VHL patients...
The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndromeR Dias
Department of Endocrinology, Barts and the London School of Medicine and Dentistry, London, UK
Horm Res 65:159-62. 2006..CONCLUSION: The LDDST was of diagnostic value by discriminating between CD and other CS aetiologies. In our view the HDDST is redundant in the investigation of paediatric CS...
Influence of growth hormone on accretion of bone massJ P Monson
Department of Endocrinology, St Bartholomew s Hospital, London, UK
Horm Res 58:52-6. 2002..To date, this has been difficult to assess in adult GHD of childhood-onset because the relative contributions of low peak bone mass and increased loss of bone in later life could not be distinguished...
Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormoneA L Ogilvy-Stuart
Department of Endocrinology, Christie Hospital NHS Trust, Manchester, UK
Clin Endocrinol (Oxf) 46:571-8. 1997..In children with hypothalamic causes for GH deficiency there are theoretical reasons why a GHRH analogue might be better than conventional GH therapy in promoting growth...
Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short statureJ C Blair
Paediatric Endocrinology Section, Department of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK
Clin Endocrinol (Oxf) 60:163-8; discussion 161-2. 2004..In the standard IGFGT, the IGF-I increase at 36 h was equal to that at 84 h. The low-dose IGFGT, in combination with the standard test, may identify patients with mild GHI...
Bilateral testicular tumours in congenital adrenal hyperplasia: a continuing diagnostic and therapeutic dilemmaD Cunnah
Department of Endocrinology, St Bartholomew s Hospital, London, UK
Clin Endocrinol (Oxf) 30:141-7. 1989..To our knowledge, this is the first time in this clinical setting that fertility has been achieved. This case highlights the need for both a functional and histological assessment of such 'tumours' in CAH prior to orchidectomy...
Two brothers with non-classical 21-hydroxylase deficiency: to treat or not to treat?F Oberender
Department of Paediatric Endocrinology and Clinical Biochemistry, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK
Horm Res 62:241-4. 2004..5 years. Because of actual or incipient virilization, both patients were treated with glucocorticoid replacement 8-12 mg/m(2)/day. This decision is discussed in the context of published guidelines for the management of 21OHD...
Embryology of the adrenal glands and its relevance to diagnostic imagingT D Barwick
Department of Diagnostic Radiology, St Bartholomew s Hospital, London, UK
Clin Radiol 60:953-9. 2005..This review article illustrates the embryology of the adrenal with particular emphasis on the relevance of embryology to pathology...
Testicular function following the treatment of Hodgkin's disease in childhoodE A Shafford
Department of Paediatric Oncology, St Bartholomew s Hospital, West Smithfield, London, UK
Br J Cancer 68:1199-204. 1993..Appropriate counselling of these patients with regard to their reproductive capabilities is essential...
Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's diseaseJ E Greening
Department of Paediatric, St. Bartholomew's and the Royal London Hospitals, London, UK
Horm Res 64:140-3. 2005..CONCLUSION: In our experience, etomidate was effective and safe for short-term control of severe hypercortisolaemia in a severely ill child...
Should recombinant human growth hormone therapy be used in short small for gestational age children?L B Johnston
Paediatric Endocrine Section, Department of Endocrinology, William Harvey Research Institute, Barts and the London Queen Mary School of Medicine, London, UK
Arch Dis Child 89:740-4. 2004..This article examines the role of GH therapy in short SGA children with particular reference to selection of patients, effectiveness, safety, and its potential metabolic implications...
Growth hormone therapy in Noonan's syndrome: non-cardiomyopathic congenital heart disease does not adversely affect growth improvementD C Brown
Child Life and Health, University of Edinburgh, London, UK
J Pediatr Endocrinol Metab 15:851-2. 2002..None of the 23 children developed hypertrophic cardiomyopathy during GH treatment. Children with any cardiac abnormality at the start of treatment did not show a reduced growth trend when compared with patients with normal hearts...
Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatmentHelen L Storr
Department of Endocrinology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London EC1A 7BE, United Kingdom
J Clin Endocrinol Metab 88:34-7. 2003..GH deficiency occurred in 86% patients. Long-term follow-up suggests some recovery of GH secretion and preservation of other anterior pituitary function...
Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivityRagnar Bjarnason
Department of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, UK
Clin Endocrinol (Oxf) 57:357-61. 2002..CONCLUSIONS: Spontaneous GH secretion is elevated in partial GH insensitivity. This investigation could be of diagnostic value in children with short stature...
Interleukin-1beta (IL-1beta) and IL-6 modulate insulin-like growth factor-binding protein (IGFBP) secretion in colon cancer epithelial (Caco-2) cellsM E Street
Department of Endocrinology, St Bartholomew s Hospital, London, UK
J Endocrinol 179:405-15. 2003..These findings suggest that interleukins modulate the IGF-IGFBP system in Caco-2 cells in vitro...
Investigating familial endocrine neoplasia syndromes in childrenL B Johnston
St Bartholomew s Hospital, London, UK
Horm Res 55:31-5. 2001..This paper provides an overview of the major features of these syndromes and suggests protocols for regular screening of children known to be at risk of developing these disorders...
Skeletal consequences of discontinuation of growth hormone at final heightWilliam M Drake
Department of Endocrinology, St Bartholomew s Hospital, London, UK
J Pediatr Endocrinol Metab 15:1351-4. 2002..This paper discusses the role of GH in the attainment of peak bone mass and some of the accumulating evidence that cessation of GH at final height may compromise bone mineral accretion in GH-deficient adolescent patients...
NESTEGG: aims and strategies. Northern European Study of Genes in GrowthLinda B Johnston
Paediatric Endocrinology Section, St. Bartholomew 's Hospital and the London Medical and Dental School, Queen Mary University of London, UK
J Pediatr Endocrinol Metab 15:1441-2. 2002
Delayed puberty associated with inflammatory bowel diseaseAnne B Ballinger
Digestive Diseases Research Centre, Department of Adult and Paediatric Gastroenterology, Barts and the London Queen Mary School of Medicine and Dentistry, London, UK
Pediatr Res 53:205-10. 2003..Observations in boys with delayed puberty and controlled studies in experimental models of intestinal inflammation suggest that testosterone therapy can accelerate puberty...
Diagnostic and therapeutic advances in growth hormone insensitivityAlessia David
Molecular Endocrinology Centre, William Harvey Research Institute, St. Bartholomew's Hospital, London, UK
Endocrinol Metab Clin North Am 34:581-95, viii. 2005....
Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndromeCecilia Camacho-Hubner
Department of Endocrinology, William Harvey Research Institute, John Vane Science Building, First Floor, Charterhouse Square, London EC1M 6BQ, United Kingdom
J Clin Endocrinol Metab 91:1246-53. 2006..We have investigated a newly developed drug, rhIGF-I/rhIGFBP-3, a 1:1 molar complex of rhIGF-I and rhIGFBP-3...
Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's diseaseHelen L Storr
Department of Endocrinology, St Bartholomew's Hospital, London, UK
Eur J Endocrinol 152:825-33. 2005....
Familial isolated primary pigmented nodular adrenocortical disease associated with a novel low penetrance PRKAR1A gene splice site mutationHelen L Storr
Queen Mary University of London, Barts and London School of Medicine and Dentistry, Centre for Endocrinology, William Harvey Research Institute, London, UK
Horm Res Paediatr 73:115-9. 2010..Most mutations result in a functionally null-allele and exhibit high penetrance. We genotyped members of an extended family for a novel PRKAR1A mutation and undertook detailed phenotyping for CNC in the affected individuals...
Gene association studies in small for gestational age infantsLinda B Johnston
Paediatric Endocrinology Section, St. Bartholomew 's Hospital and the London Medical and Dental School, Queen Mary University of London, UK
J Pediatr Endocrinol Metab 15:1459. 2002
Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populationsLinda B Johnston
Department of Endocrinology, Barts and the London Queen Mary School of Medicine, University of London, London, United Kingdom
J Clin Endocrinol Metab 88:4805-10. 2003..These studies validate the association of the IGF-I gene with birth size and refine the region of association in Swedish short SGA subjects...
Network of European studies of genes in growth (NESTEGG)Linda B Johnston
Barts and the London Queen Mary School of Medicine, London, UK
Horm Res 71:48-54. 2009..This article describes the study methodology and reviews the association of the exon 3-deleted genotype of the GH receptor with GH responsiveness in GH-treated children born SGA...
Pediatric Cushing's syndrome: clinical features, diagnosis, and treatmentLi F Chan
Department of Endocrinology, William Harvey Research Institute, St Bartholomew s and the Royal London School of Medicine and Dentistry
Arq Bras Endocrinol Metabol 51:1261-71. 2007..This article will aim to provide an overall view of pediatric CS highlighting some of the differences between adult and pediatric CS...
Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I geneK A Woods
Department of Endocrinology, St. Bartholomew's Hospital, London, United Kingdom
N Engl J Med 335:1363-7. 1996
Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosisHelen L Storr
Department of Endocrinology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, West Smithfield, London, United Kingdom EC1A 7BE
J Clin Endocrinol Metab 89:3818-20. 2004..In conclusion, female preponderance of CD in adult patients was not present in childhood. In patients 18 yr of age or younger, there was no difference in the severity of hypercortisolemia or ACTH at diagnosis between males and females...
Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advancesHelen L Storr
Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary s School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK
Trends Endocrinol Metab 18:167-74. 2007..The management of paediatric CS patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn diseaseKaushik Bannerjee
Departments of Adult and Paediatric Gastroenterology, Barts and The London, Queen Mary's School of Medicine and Dentistry, University of London, London, United Kingdom
J Pediatr Gastroenterol Nutr 38:270-5. 2004..CONCLUSIONS: Early increases in IGF-I during treatment of Crohn disease are attributable to the anti-inflammatory effect of the enteral feed rather than nutritional restitution...
Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivityAlessia David
Department of Endocrinology, Barts and the London School of Medicine and Dentistry, London, United Kingdom
Endocr Rev 32:472-97. 2011....
Pseudo-precocious puberty caused by a juvenile granulosa cell tumour secreting androstenedione, inhibin and insulin-like growth factor-IL F Chan
Department of Paediatric Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK
J Pediatr Endocrinol Metab 17:679-84. 2004..Histological changes were consistent with JGCT. Immunohistochemical studies revealed positive reactivity to MIC-2, inhibin, melan A, IGF-I and IGFBP-2...
TPIT mutations are associated with early-onset, but not late-onset isolated ACTH deficiencyL A Metherell
Department of Endocrinology, Barts and The London, Queen Mary University of London, London, UK
Eur J Endocrinol 151:463-5. 2004..Recently, mutations in the TPIT gene, a T-box factor selectively expressed in developing corticotroph cells, have been found in cases of early-onset IAD...
Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivityL A Metherell
Department of Chemical Endocrinology, St. Bartholomew's Hospital, London EC1A 7BE, United Kingdom
Am J Hum Genet 69:641-6. 2001..The presence of the pseudoexon results in inclusion of an additional 36-amino acid sequence in a region of the receptor known to be involved in homo-dimerization, which is essential for signal transduction...
Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in childrenAndrew Sawczenko
Research Centre for Gastroenterology, Institute of Cell and Molecular Science, University of London, London E1 2AD, United Kingdom
Proc Natl Acad Sci U S A 102:13260-5. 2005..028). However, their risk of developing Crohn's disease was similar to other genotypes when compared with 351 healthy controls (P = 0.7). Thus, the IL-6 -174 genotype mediates growth failure in children with Crohn's disease...
Final height in patients with idiopathic short stature and high growth hormone responses to stimulation testsCarlos Eduardo Martinelli
Department of Paediatrics, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil
Horm Res 67:224-30. 2007..0 standard deviation score (SDS) if untreated. FH of subjects with high stimulated GH levels has not been studied in detail...
Deterioration of visual acuity associated with growth hormone therapy in a child with extreme short stature and high hypermetropiaWendy F Paterson
Department of Child Health, Royal Hospital for Sick Children, Glasgow, UK
Horm Res 67:67-72. 2007..In 1998, an association between exogenous human GH and retinal pathology in non-diabetic subjects was described...
The 88th Annual Meeting of the Endocrine Society, June 24-27, 2006, Boston MA, USA: selected pediatric presentationsMitchell E Geffner
The Saban Research Institute of Childrens Hospital, Los Angeles, CA, USA
Pediatr Endocrinol Rev 5:789-95. 2008
Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel diseaseMaria E Street
Department of Paediatrics, University of Parma, Italy
Horm Res 61:159-64. 2004..To study the relationships between serum IGF-1, IGFBP-3 and IGFBP-2 and interleukin (IL)-1beta and IL-6 in inflammatory bowel disease (IBD)...
The GH-IGF-I axis in children with idiopathic short statureJoanne C Blair
Section of Paediatric Endocrinology, Dept of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK EC1A 7BE
Trends Endocrinol Metab 13:325-30. 2002..Because most diagnostic methods remain crude, however, their modification might be necessary to identify more subtle and yet functionally significant abnormalities of this endocrine axis...
Novel growth hormone receptor mutation in a Chinese patient with Laron syndromeHamilton N T Hui
Department of Paediatrics and Adolescent Medicine, United Christian Hospital, Hong Kong, China
J Pediatr Endocrinol Metab 18:209-13. 2005..9 years with height -4.9 SDS, basal GH 344 mIU/ml, IGF-I <12 ng/ml, IGFBP-3 <0.2 mg/ml, and undetectable GHBP. A novel mutation of the GHR, not previously described, was identified at the donor splice site of intron 6...
Hypopituitarism in childhood and adolescence following traumatic brain injury: the case for prospective endocrine investigationCarlo L Acerini
Department of Paediatrics, University of Cambridge, Cambridge, UK
Eur J Endocrinol 155:663-9. 2006..We urge paediatric endocrinologists, in collaboration with adult endocrinologists, to perform formal prospective research studies in patients suffering from TBI to clarify these questions...
The small for gestational age childLinda B Johnston
Best Pract Res Clin Endocrinol Metab 22:vii. 2008
Cushing's disease in children and adolescents: 20 years of experience in a single neurosurgical centerShabin M Joshi
Department of Neurosurgery, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, England
Neurosurgery 57:281-5; discussion 281-5. 2005..We found the use of intraoperative neuronavigation to be an excellent aid in overcoming such anatomic difficulties...
Hyperplasia of adrenal rest tissue causing a retroperitoneal mass in a child with 11 beta-hydroxylase deficiencyHelen L Storr
Department of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK
Horm Res 60:99-102. 2003..Complete resolution of the mass was noted after 18 months of hydrocortisone replacement therapy...
Clinical features affecting final adult height in patients with pediatric-onset Crohn's diseaseAndrew Sawczenko
Research Centre in Gastroenterology, Institute of Cell and Molecular Science, Barts and The London, Turner Street, London E1 2AD, United Kingdom
Pediatrics 118:124-9. 2006..Earlier diagnosis and improved treatment of jejunal disease would be likely to improve final height...
Growth hormone insensitivity and severe short stature in siblings: a novel mutation at the exon 13-intron 13 junction of the STAT5b geneVivian Hwa
Department of Pediatrics, Oregon Health and Sciences University, Portland, OR 97239 3098, USA
Horm Res 68:218-24. 2007..We investigated 2 sisters from a consanguineous family from Kuwait, with clinical and biochemical features of GHI, in whom no molecular defects in the GHR were identified...
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice GuidelineLynnette K Nieman
Program on Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA
J Clin Endocrinol Metab 93:1526-40. 2008..The objective of the study was to develop clinical practice guidelines for the diagnosis of Cushing's syndrome...
